- Type
- not stated
- Format
- Structured JSON (explicitly supported for registry export/import — the most machine-consumable format in this cohort) plus locally-stored 21 CFR Part 11 audit-trail records with time-stamped, reproducible schedule and QC results; DICOM metadata for acquisition QC
- Volume
- Small volume, unusually high structure: on the order of tens of protocol definitions and hundreds of registered sites in the central registries, plus per-trial generated schedules and a growing set of DICOM acquisition QC verdicts (inferred: the registries are curated rather than accumulated, and the tool is deployed on the subset of trials where Oncosia is the expert vendor)
- Users
- ~5-50 named licensed users (inferred: a 2-person GmbH selling standalone licences with evaluation access plus a trial-vendor channel, so deployment is measured in trial teams and individual nuclear medicine departments; realistic scope is the sites of the trials where Oncosia is the named expert vendor, not a broad installed base)
- History
- 3 years
- Update frequency
- not stated
- Growth
- Active and early — four solution lines presented (clinical routine dosimetry, clinical trials & research, calibration/reference QC products, NuQ toolbox), a current site build with embedded product video, evaluation-access funnel, and an open careers page; modules are stated to be in active use on live trials where Oncosia is the expert vendor
- Launched
- ~2023-2026 for the NuQ toolbox (inferred: a 2-person GmbH with a recently-created vendor record, no funding history, a modern marketing site with self-produced product video and an evaluation funnel points to a recent product launch; the underlying dosimetry and calibration-reference expertise line appears to predate the software)
- Delivery
- not stated
- Entity mapping
- not stated
- Sample
- not stated
- Point-in-time
- not stated
- Licence
- not stated